CD47 and cancer: Despite the fact that many cancers exploit this mechanism through increasing CD47 expression, and thereby evade attack by phagocytes, we previously found that mere depletion of the CD47-SIRPα axis or SIRPα-mediated inhibitory signaling does not lead to phagocytosis11.